Modafinil and sleep — what it does and doesn’t do

Modafinil promotes wakefulness. It is not a sleep drug, not a sleep aid, and not a substitute for sleep.

The position

Modafinil is a wakefulness-promoting compound. Anyone looking for help falling asleep, staying asleep, or recovering from chronic sleep loss should consult sleep hygiene literature and a qualified physician, not look at modafinil.

The FDA-approved sleep-disorder indications

Three of modafinil’s FDA-approved uses are sleep-disorder-related: narcolepsy, shift-work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. In each, the drug treats the daytime alertness deficit, not the underlying sleep architecture. CPAP remains the standard treatment for sleep apnea; modafinil is adjunctive in that setting.

Dose at wake-up, the standard timing

Half-life is 12 to 15 hours. A morning dose remains pharmacologically active across the day. The most common cause of next-day insomnia complaints in first-time users is afternoon dosing. The standard protocol is to dose at wake-up; the modafinil window then closes naturally over the workday.

Modafinil is not a substitute for sleep

Sleep performs functions modafinil does not replicate, memory consolidation, glymphatic clearance, cellular repair, immune regulation. Using the drug to substitute for chronic sleep loss is a use case razumna does not recommend. The wakefulness effect is real; the cost of running the system without recovery is also real, and the drug does not change that.

Related

For the standard dosing protocol, see modafinil dosage. For the mechanism behind the wakefulness effect, see how modafinil works. For the side-effect profile, see modafinil side effects.